- 保存方法Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
- バッファーpH: 7.30
Preservative: 0.02% Sodium azide
Constituents: 50% Glycerol, 1% BSA, 48% PBS
Concentration information loading...
- 精製度Protein A purified
- 特記事項（精製）ab119051 is purified from Mouse ascite fluid by affinity chromatography.
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/2000. Predicted molecular weight: 35 kDa.
||1/100. ab170191-Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.
- 機能Required for synthesis of pyridoxal-5-phosphate from vitamin B6.
- 組織特異性Ubiquitous. Isoform 3 is detected in adult testis and spermatozoa.
- 配列類似性Belongs to the pyridoxine kinase family.
Information by UniProt
- pdxK antibody
- PDXK_HUMAN antibody
- PKH antibody
Anti-PDXK.1 antibody [5H5] 画像
Western blot - Anti-PDXK.1 antibody [5H5] (ab119051)
All lanes : Anti-PDXK.1 antibody [5H5] (ab119051) at 1/2000 dilution
Lane 1 : HEK293T lysate transfected with pCMV6-ENTRY control cDNA
Lane 2 : HEK293T lysate transfected with pCMV6-ENTRY PDXK.1 cDNA
Lysates/proteins at 5 µg per lane.
Predicted band size : 35 kDa
HEK293T cell lysates were generated from transient transfection of the cDNA clone (RC200975)
Immunocytochemistry/ Immunofluorescence - Anti-PDXK.1 antibody [5H5] (ab119051)
ab119051 at 1/100 dilution staining PDXK.1 in COS7 cells transiently transfected with pCMV6-ENTRY PDXK.1 by Immunofluorescence.
Flow Cytometry - Anti-PDXK.1 antibody [5H5] (ab119051)
ab119051 at 1/100 dilution staining PDXK.1 in HEK293T cells transfected with either pCMV6-ENTRY PDXK.1 overexpress plasmid(Red) or empty vector control plasmid(Blue) by flow cytometry.
Anti-PDXK.1 antibody [5H5] (ab119051) 使用論文
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"